GENERAL CATALOGUE
TB22
HY-162939 · 50 mg
MedChemExpress · Cat: HY-162939
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/tb22.html
Sponsored
Catalog No: HY-162939
Category: Epigenetics
Pack Size: 50 mg
Brand: MedChemExpress
Description
TB22 is a non-nucleoside inhibitor of DOT1LR231Q, possessing anticancer activity. TB22 inhibits the malignant phenotype of lung cancer cells carrying the R231Q mutation through the MAPK/ERK signaling pathway, and can be used for lung cancer research.
More from MedChemExpress
H
hsa-miR-4268 antagomir
HY-RI00947A
Epigenetics
H
hsa-miR-4731-5p antagomir
HY-RI01332A
Epigenetics
F
FRMD3 Human Pre-designed siRNA Set A
HY-RS05100
Epigenetics
M
MAPK12 Human Pre-designed siRNA Set A
HY-RS08101
Epigenetics
N
NEURL1 Human Pre-designed siRNA Set A
HY-RS09219
Epigenetics
L
LRFN2 Human Pre-designed siRNA Set A
HY-RS07782
Epigenetics
Luteolin 7-sulfate
HY-N6901
Epigenetics
VRTN Human Pre-designed siRNA Set A
HY-RS15705
Epigenetics